Abstract
Representative longitudinal muscle strips (6 × 10 mm) from proximal and distal small intestine were excised from control and streptozotocin-treated rats after one month of untreated and insulin-treated diabetes. Untreated diabetes significantly reduced tissue concentrations of vasoactive intestinal polypeptide (VIP) at both intestinal loci. Insulin treatment of the diabetic animals restored tissue VIP concentrations to control group levels, although the beneficial effect of insulin treatment was only significant in the duodenum. Spontaneous release of VIP was significantly attenuated by untreated diabetes at both intestinal sites. In the duodenum, insulin treatment of the diabetic animals restored VIP release to levels indistinguishable from control group values. In the ileum, insulin treatment produced levels of VIP release that were not significantly different from those of the control and untreated diabetic groups. Tetrodotoxin (5 × 10−6 M) significantly—but incompletely—inhibited VIP release from control group animals at both intestinal sites. These observations indicate that diabetes mellitus significantly diminishes VIP tissue concentrations and release from intestinal myenteric nerves. These abnormalities improve with insulin treatment. However, the mechanisms of VIP release from proximal and distal intestine appear to differ not only in their response to the diabetic state, but also in their response to insulin treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Feldman M, Schiller LR: Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98:378–384, 1983
Smith B: Neuropathology of the oesophagus in diabetes mellitus. J Neurol Neurosurg Psychiatry 37:1151–1154, 1974
Hensley GT, Soergel KH: Neuopathologic findings in diabetic diarrhea. Arch Pathol 85:587–597, 1968
Schmidt RE, Plurad DA, Roth KA: Effect of chronic experimental streptozotocin-induced diabetes on the noradrenergic and peptidergic innervation of the rat alimentary tract. Brain Res 458:353–360, 1988
Lincoln J, Bokor JT, Crowe R, Griffith SG, Haven AJ, Burnstock G: Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut. Gastroenterology 86:654–661, 1984
Dockray GJ: Physiology of enteric neuropeptides.In Physiology of the Gastrointestinal Tract, 2nd ed. LR Johnson, (ed). New York: Raven Press, 1987, pp 41–66
Bitar KN, Said SI, Weir GC, Saffouri B, Makhlouf GM: Neural release of vasoactive intestinal peptide from the gut. Gastroenterology 79:1288–1294, 1980
Chijiiwa Y, Misawa T, Ibayashi H: Evidence of local mechanism involvement in vasoactive intestinal polypeptide release from canine small intestine. Gastroenterology 90:1877–1881, 1986
Kusunoki M, Tsai LH, Taniyama K, Tanaka C: Vasoactive intestinal polypeptide provokes acetylcholine release from the myenteric plexus. Am J Physiol 251:G51-G55, 1986
Loesch A, Belai A, Lincoln J, Burnstock G: Enteric nerves in diabetic rat: Electron microscopic evidence for neuropathy of vasoactive intestinal polypeptide-containing fibres. Acta Neuropathol 70:161–168, 1986
Nowak TV, Harrington B, Kalbfleisch JH, Amatruda JM: Evidence for abnormal cholinergic neuromuscular transmission in diabetic rat small intestine. Gastroenterology 91:124–132, 1986
Ballmann M, Conlon JM: Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat. Diabetologia 28:355–358, 1985
Belai A, Lincoln J, Milner P, Crowe R, Loesch A, Burnstock G: Enteric nerves in diabetic rats: Increase in vasoactive intestinal polypeptide but not substance P. Gastroenterology 89:967–976, 1985
Nowak TV, Harrington B, Weisbruch JP, Kalbfleisch JH: Structural and functional characteristics of muscle from diabetic rodent small intestine. Am J Physiol 258:G690-G698, 1990
Belai A, Lincoln J, Burnstock G: Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats. Gastroenterology 93:1034–1040, 1987
Chang TM, Roth FL Jr, Tai H-H, Chey WY: Radioimmunoassay of vasoactive intestinal polypeptide. Anal Biochem 97:286–297, 1979
Kishimoto S, Kunita S, Kambara A, Okamoto K, Shimuzu S, Yamamoto M, Koh H, Sano K, Kajiyama G, Myoshi A, Yanaihara N: VIPergic innervation of the gastrointestinal tract of diabetic rats. Hiroshima J Med Sci 32:469–478, 1983
Belai A, Burnstock G: Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozotocin-diabetic rat ileum. Gastroenterology 98:1427–1436, 1990
Schmidt RE, Plurad SB, Saffitz JE, Grabau GG, Yip HK: Retrograde axonal transport of125I-nerve growth factor in rat ileal mesenteric nerves. Effect of streptozotocin diabetes. Diabetes 34:1230–1240, 1985
Tomlinson DR, Myer JH: Defects of axonal transport in diabetes mellitus—a possible contribution to the aetiology of diabetic neuropathy. J Auton Pharmacol 4:59–72, 1984
Tomlinson DR, Robinson JP, Willars GB, Keen P: Deficient axonal transport of substance P in streptozotocin-induced diabetic rats. Effects of sorbinil and insulin. Diabetes 37:488–493, 1988
Cocks T, Burnstock G: Effects of neuronal polypeptides on intestinal smooth muscle: A comparison with non-adrenergic, non-cholinergic nerve stimulation and ATP. Eur J Pharmacol 54:251–259, 1979
Cohen ML, Landry AS: Vasoactive intestinal polypeptide: Increased tone, enhancement of acetylcholine release, and stimulation of adenylate cyclase in intestinal smooth muscle. Life Sci 26:811–822, 1980
Johns A: The effect of vasoactive intestinal polypeptide on the urinary bladder and taenia coli of the guinea pig. Can J Physiol Pharmacol 57:106–108, 1979
Yagasaki O, Nabata H, Yanagiya I: Effects of desensitization to adenosine 5′-triphosphate and vasoactive intestinal polypeptide on non-adrenergic inhibitory responses of longitudinal and circular muscles in the rat ileum. J Pharm Pharmacol 35:818–820, 1983
Yau WM, Youther ML, Verdun PR: A presynaptic site of action of substance P and vasoactive intestinal polypeptide on myenteric neurons. Brain Res 330:382–385, 1985
Belai A, Lincoln J, Milner P, Burnstock G: Progressive changes in adrenergic, serotoninergic, and peptidergic nerves in proximal colon of streptozotocin diabetic rats. Gastroenterology 95:1234–1241, 1988
Nowak TV, Harrington B, Kalbfleisch J: Adaptation of cholinergic enteric neuromuscular transmission in diabetic rat small intestine. Diabetes 39:891–897, 1990
Schmidt RE, Nelson JS, Johnson EM, Jr: Experimental diabetic autonomic neuropathy. Am J Pathol 103:210–225, 1981
Author information
Authors and Affiliations
Additional information
This work was supported by a research grant from the Department of Veterans Affairs and by a grant (R29 DK38863-05) from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Nowak, T.V., Chey, W.W., Chang, TM. et al. Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestine. Digest Dis Sci 40, 828–836 (1995). https://doi.org/10.1007/BF02064987
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02064987